Status:
COMPLETED
Molecular and Immunological Tools for Detection of Strain Diversity, Drug Resistance and Immunological Responses
Lead Sponsor:
Colorado State University
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Leprosy
Eligibility:
All Genders
18-70 years
Brief Summary
The purpose of this study is to determine what factors contribute to the continued incidence of leprosy in Colombia. Study participants will include volunteering and consenting individuals, older than...
Detailed Description
The overall objectives of this study are to understand the factors leading to continued incidence of leprosy in Colombia by novel molecular methodologies using a combination of retrospective and prosp...
Eligibility Criteria
Inclusion
- All leprosy patients (Group1), their household contacts (Group 2) and healthy persons with no known contacts with leprosy patients (Group 3), between the ages of 18 and 70 years willing to participate in this study.
Exclusion
- Patients unwilling to participate or unable to give informed consent will be excluded from the study.
- Pregnant women will be excluded.
- Exclusion criteria for objective A.5 are one or more of the following conditions:
- Chronic illnesses such as cancer
- Diabetes
- Hepatitis
- HIV
- Tuberculosis
- Undergoing corticosteroid therapy
- Current or previous history of immunosuppressive therapy as assessed from medical records and interviews with a physician.
Key Trial Info
Start Date :
April 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
1554 Patients enrolled
Trial Details
Trial ID
NCT00138437
Start Date
April 1 2006
End Date
April 1 2013
Last Update
November 7 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Impresa Socail del Estado Sanatorio Agua de Dios
Agua de Dios, Colombia
2
Instituto Colombiano de Medicina Tropical-CES
Sabaneta, Colombia